Kovitz Investment Group Partners
TECH icon

Kovitz Investment Group Partners’s Bio-Techne TECH Stock Holding History

Kovitz Investment Group Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,773
Closed -$599K – 1232
2025
Q3 		$599K Buy
+10,773
New +$577K ﹤0.01% 975
2025
Q1 		– Sell
-3,069
Closed -$221K – 1317
2024
Q4 		$221K Buy
+3,069
New +$225K ﹤0.01% 1136

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kovitz Investment Group Partners's TECH Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 10,773 shares — an estimated $599K sold.

Kovitz Investment Group Partners first reported a position in TECH in Q4 2024 and held it in 2 quarters. The position peaked at $599K in Q3 2025. 585 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 10,773 Bio-Techne shares in Q4 2025, an estimated $599K.
  • Kovitz Investment Group Partners first reported a position in Bio-Techne in Q4 2024 and held it in 2 quarters.
  • Kovitz Investment Group Partners's Bio-Techne position peaked at $599K in Q3 2025.
  • 585 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.